(firstQuint)Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis.

 This will be an open-label, non-comparative study of intravenous FK463.

 Enrollment will include at least 100 patients evaluable for efficacy.

.

 Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis@highlight

The purpose of the study is to evaluate the safety and efficacy of FK463 in the treatment of patients with confirmed candidemia or invasive candidiasis.

